(Q36066076)

12 August 2017

1 reference

title

Biliary tract cancers: current concepts and controversies (English)

1 reference

12 August 2017

Gregory D Leonard

1

1 reference

12 August 2017

Eileen M O'Reilly

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

211-223

1 reference

Malignancies of the biliary tree

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Gallstones, cholecystectomy and risk of cancers of the liver, biliary tract and pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Lifestyle, parity, menstrual and reproductive factors and risk of gallbladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

K-ras oncogene mutation in cancer and precancerous lesions of the gallbladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

The molecular pathogenesis of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Preneoplastic lesions and gallbladder cancer: an estimate of the period required for progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Positron-emission tomography with fluorine-18-fluoro-2-deoxy-D-glucose for gallbladder cancer diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Carcinoma of the gallbladder. Staging, treatment, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Portal vein resection and reconstruction prior to hepatic dissection during right hepatectomy and caudate lobectomy for hepatobiliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Should suspected early gallbladder cancer be treated laparoscopically?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Subclinical gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Extended cholecystectomy for carcinoma of the gallbladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Radical surgery for gallbladder carcinoma. Long-term results

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Treatment of gallbladder cancer by radical resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Irradiation therapy for gallbladder carcinoma: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Gallbladder carcinoma: role of radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Radiation therapy of carcinoma of gallbladder and biliary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Imaging of the hepatobiliary tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Outcome of treatment for distal bile duct cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

A phase II trial of tegafur-uracil plus leucovorin (LV) in the treatment of advanced biliary tract carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

CPT-11 for bile-duct and gallbladder carcinoma: a phase II North Central Cancer Treatment Group (NCCTG) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Phase II Trial of the Use of Gemcitabine and 5-Fluorouracil in the Treatment of Advanced Pancreatic and Biliary Tract Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Gemcitabine and Cisplatin Is a Highly Effective Combination Chemotherapy in Patients With Advanced Cancer of the Gallbladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Phase II study of cisplatin, epirubicin, and continuous-infusion 5-fluorouracil for advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Phase I dose-finding study of biweekly irinotecan in combination with fixed doses of 5-fluorouracil/leucovorin, gemcitabine and cisplatin (G-FLIP) in patients with advanced pancreatic cancer or other solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.2.211

21 January 2018

Identifiers

DOI

10.1517/14656566.6.2.211

1 reference

12 August 2017

1 reference